Citations

Clear

3138 citation(s) found for "Smith, AM".

Detection of Smallpox Virus DNA by LightCycler PCR
Espy, Mark J., Cockerill, Franklin R., Meyer, Richard F. , Bowen, Michael D. , Hadfield, Ted L., Smith, Thomas F., Poland, Gregory A.

Mayo Clinic

Journal of Clinical Microbiology | July 27, 2002 | Volume: 40 | Issue: 6 | Pages: 1985-1988

10.1128/jcm.40.6.1985-1988.2002 | PMID 12037052 Get It

ABSTRACT A 300-bp plasmid fragment of the hemagglutinin gene was used as target DNA to develop a rapid real-time LightCycler (Roche Applied Science, Indianapolis, Ind.) PCR assay for laboratory detection of smallpox virus. PCR primers and probes were designed specifically for detection of smallpox virus DNA, but all viruses of the genus Orthopoxvirus tested could be detected by use of the hemagglutinin gene target sequence. Base pair mismatches in the 204-bp amplicon allowed discrimination of cowpox virus (melting temperature [ T m ], 56.40°C), monkeypox virus ( T m , 56.24°C), and vaccinia virus ( T m , 56.72°C), including the Dryvax vaccine strain, from smallpox virus ( T m , 62.45°C) by melting curve analysis. The analytical sensitivity was 5 to 10 copies of target DNA per sample. The assay was specific for members of the genus Orthopoxvirus ; the DNAs of herpes simplex virus and varicella-zoster virus were not detected by the smallpox virus LightCycler PCR.
Comparative Quantitation of Cytomegalovirus (CMV) DNA in Solid Organ Transplant Recipients with CMV Infection by Using Two High-Throughput Automated Systems
Brown, Robert A. , Espy, Mark J., Kremers, Walter K. , Groettum, Cynthia, Smith, Thomas F., Payá, Carlos V., Razonable, Raymund R. , Rivero, Antonio , Wilson, Jennie , Kremers, Walter K

Mayo Clinic

Journal of Clinical Microbiology | July 27, 2002 | Volume: 39 | Issue: 12 | Pages: 4472-4476

10.1128/jcm.39.12.4472-4476.2001 | PMID 11724864 Get It

ABSTRACT Cytomegalovirus (CMV) DNA quantitation in clinical specimens is progressively becoming a cornerstone in the diagnosis and management of CMV infection in the immunocompromised host. We evaluated two automated and reproducible PCR tests, the LightCycler (Roche Molecular Biochemicals, Indianapolis, Ind.) and the COBAS AMPLICOR CMV Monitor (Roche Diagnostics, Pleasanton, Calif.), for the detection of CMV DNA in blood samples from transplant recipients with CMV infection as determined by shell vial culture. Following a log transformation analysis, the mean CMV DNA in plasma (PL), whole blood (WB), peripheral blood leukocytes (PBL), and peripheral blood mononuclear cells (PBMC) using the LightCycler was 6.79 copies per ml, 7.23 copies per ml, 6.38 copies per 2 × 10 6 cells, and 6.27 copies per 2 × 10 6 cells, respectively. This compares to 7.86 copies per ml, 8.37 copies per ml, 7.59 copies per 2 × 10 6 cells, and 7.44 copies per 2 × 10 6 cells, respectively, using COBAS AMPLICOR CMV Monitor. While higher CMV DNA levels were observed for the various blood compartments analyzed using COBAS AMPLICOR CMV Monitor, a high degree of correlation was evident between the two automated systems (jackknife correlation r = PL 0.77 [95% confidence interval (CI); 0.64, 0.90], WB 0.77 [95% CI; 0.62, 0.92], PBL 0.77 [95% CI; 0.67, 0.88], and PBMC 0.81 [95% CI; 0.72, 0.89], all P < 0.001). Therefore, we conclude that either automated diagnostic system is accurate for CMV DNA quantitation.
Detection of Herpes Simplex Virus DNA in Genital and Dermal Specimens by LightCycler PCR after Extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 Methods
Espy, Mark J., Rys, Paul N., Wold, Arlo D., Uhl, James R., Sloan, Lynne M., Jenkins, G. Douglas , Ilstrup, Duane M., Cockerill, F. R., Patel, Robin , Rosenblatt, Jon E., Smith, Thomas F., Cockerill, Franklin R., Patel, Robin

Mayo Clinic

Journal of Clinical Microbiology | July 27, 2002 | Volume: 39 | Issue: 6 | Pages: 2233-2236

10.1128/jcm.39.6.2233-2236.2001 | PMID 11376062 Get It

ABSTRACT We evaluated two automated systems, MagNA Pure (Roche Molecular Biochemicals, Indianapolis, Ind.) and BioRobot 9604 (Qiagen, Inc., Chatsworth, Calif.) as effective replacements for the manual IsoQuick method (Orca Research, Inc., Bothell, Wash.) for extraction of herpes simplex virus (HSV) DNA from dermal and genital tract specimens prior to analysis by LightCycler PCR. Of 198 specimens (152 genital, 46 dermal), 92 (46.2%) were positive for HSV DNA by LightCycler PCR after automated extraction of specimens with either the MagNA Pure or BioRobot 9604 instrument. The manual IsoQuick method yielded HSV DNA (total n = 95) from three additional specimens that were negative by the automated method ( P = 0.25, sign test). Although the mean numbers of LightCycler PCR cycles required to reach positivity differed statistically significantly among all three of the methods of extraction, the estimated means differed by no more than 1.5 cycles ( P < 0.05). Seventy (76%) of the 92 specimens that were LightCycler PCR positive by all three extraction methods were also positive by shell vial cell culture assay. HSV DNA was detected by a lower LightCycler PCR cycle number (26.1 cycles) in specimens culture positive for the virus than in culture-negative samples (33.3 cycles) ( P < 0.0001). The manual IsoQuick and automated MagNA Pure and BioRobot 9604 methods provide standardized, reproducible extraction of HSV DNA for LightCycler PCR. The decision to implement a manual versus an automated procedure depends on factors such as costs related to the number of specimens processed rather than on the minimal differences in the technical efficiency of extraction of nucleic acids among these methods.
Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant Recipients
Payá, Carlos V., Smith, Thomas F., Razonable, Raymund R.

Mayo Clinic

Journal of Clinical Microbiology | July 27, 2002 | Volume: 40 | Issue: 3 | Pages: 746-752

10.1128/jcm.40.3.746-752.2002 | PMID 11880387 Get It

Effects of in vivo adventitial expression of recombinant endothelial nitric oxide synthase gene in cerebral arteries
Chen, Alex F.Y., Jiang, Shi-Wen, Crotty, Thomas B., Tsutsui, Masato , O’Brien, Timothy , Katušić, Zvonimir S. , Jiang, Shi‐Wen , Smith, Leslie

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 94 | Issue: 23 | Pages: 12568-12573

10.1073/pnas.94.23.12568 | PMID 9356490 Get It

Nitric oxide (NO), synthesized from l -arginine by NO synthases (NOS), plays an essential role in the regulation of cerebrovascular tone. Adenoviral vectors have been widely used to transfer recombinant genes to different vascular beds. To determine whether the recombinant endothelial NOS (eNOS) gene can be delivered in vivo to the adventitia of cerebral arteries and functionally expressed, a replication-incompetent adenoviral vector encoding eNOS gene (AdCMVNOS) or β-galactosidase reporter gene (AdCMVLacZ) was injected into canine cerebrospinal fluid (CSF) via the cisterna magna (final viral titer in CSF, 10 9 pfu/ml). Adventitial transgene expression was demonstrated 24 h later by β-galactosidase histochemistry and quantification, eNOS immunohistochemistry, and Western blot analysis of recombinant eNOS. Electron microscopy immunogold labeling indicated that recombinant eNOS protein was expressed in adventitial fibroblasts. In AdCMVNOS-transduced arteries, basal cGMP production and bradykinin-induced relaxations were significantly augmented when compared with AdCMVLacZ-transduced vessels ( P < 0.05). The increased receptor-mediated relaxations and cGMP production were inhibited by eNOS inhibitors. In addition, the increase in cGMP production was reversed in the absence of calcium, suggesting that the increased NO production did not result from inducible NOS expression. The present study demonstrates the successful in vivo transfer and functional expression of recombinant eNOS gene in large cerebral arteries. It also suggests that perivascular eNOS gene delivery via the CSF is a feasible approach that does not require interruption of cerebral blood flow.
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”
Aquino, Christopher, Armour, Duncan, Berman, Judd, Birkemo, Larry S., Carr, Robin A. E., Croom, Dallas K., Dezube, Milana, Dougherty, R. W., Ervin, Gregory N., Grizzle, Mary K., Head, Julie E., Hirst, Gavin C. , James, Michael K. , Johnson, Michael F., Queen, Kennedy L., Rimele, Thomas J., Smith, David Norman , Sugg, Elizabeth E., Miller, Laurence J.

Mayo Clinic

Journal of Medicinal Chemistry | July 26, 2002 | Volume: 39 | Issue: 2 | Pages: 562-569

10.1021/jm950626d | PMID 8558528 Get It

Platelet Responses to Compound Interactions with Thrombin
Smith, Reginald D. , Owen, Whyte G.

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 38 | Issue: 28 | Pages: 8936-8947

10.1021/bi9827518 | PMID 10413467 Get It

Clinicopathologic Study of Ectomesenchymomas from Intergroup Rhabdomyosarcoma Study Groups III and IV
Boué, Daniel R. , Parham, David M. , Crist, William M., Qualman, Stephen J., Office, from the Intergroup Rhabdomyosarcoma Study Group (IRSG) representing the Children's Cancer Group, the Pediatric Oncology Group,, Anderson, James R., Breitfeld, Richard J., Breneman, John C. , Bridge, Julia A. , Brown, Kenneth L. , Grier, Holcombe E. , Houghton, Peter J. , Link, Michael P., Lobe, Thom L., Maurer, Harold M., Meyer, William H. , Michalski, Jeff M. , Murphy, Sharon, Raney, R. Beverly, Robison, Leslie, Skapek, Stephen X. , Teot, Lisa A., Vietti, Teresa J., Walterhouse, David , Wharam, Mondy, Wiener, Eugene S. , Womer, Richard B. , Webber, Bruce L. , Office, from the Intergroup Rhabdomyosarcoma Study Group (IRSG) representing the Children's Cancer Group, the Pediatric Oncology Group, and the Intergroup Rhabdomyosarcoma Statistical, Anderson, James R., Donaldson, Sarah S. , Hawkins, Douglas S. , Paidas, Charles N. , Pappo, Alberto S. , Sandler, Eric , Smith, Lynn , Sorensen, Poul H. , Spunt, Sheri L. , Triche, Timothy J. , Wolden, Suzanne L.

Mayo Clinic

Pediatric and Developmental Pathology | July 25, 2002 | Volume: 3 | Issue: 3 | Pages: 290-300

10.1007/s100249910039 | PMID 10742419 Get It

Ectomesenchymomas (EM) are rare malignant neoplasms usually consisting of rhabdomyosarcoma (RMS) with a neural component. Only 21 cases have been previously reported. Here we extend the clinicopathologic spectrum of EM by describing our findings in 15 cases. Only 5 patients were infants; 10 were ≤3 years old and 5 were ≥6 years old. No male predilection was observed; 7 were female. The originating institutional diagnoses were; RMS (12), undifferentiated sarcoma (1), or EM (2), suggesting underdiagnosis of this entity. The primary tumor sites included external genital (5), pelvis/abdomen (6), head and neck (3), and extremity (1). The size of the primary neoplasm was usually ≥5 cm at diagnosis but dissemination only occurred in a minority. Local infiltration was not uncommon. These neoplasms were typically multilobate, thinly encapsulated, hemorrhagic, and necrotic. Light microscopic features were highly variable, but embryonal RMS with scattered or clustered ganglion cells, often in lacunae, was characteristic. In some cases, primitive neuroblastic or neuroectodermal areas were found and/or a component of alveolar RMS was seen. Focal anaplasia was occasionally observed. Mitotic activity appears higher than previously appreciated and some necrosis was invariably present. Electron microscopy was performed in 11 cases, which confirmed skeletal muscle ± neural differentiation. Cytogenetic studies performed in five cases revealed no specific abnormality. Monoclonal neuron-specific enolase was the best marker of ganglion cells and primitive neural elements. MIC-2 (CD99) membrane expression was not definitively present in any of the six cases examined. A number of the above parameters appear to be of some prognostic significance, but overall, these neoplasms appear to have a similar outcome as would be predicted for their RMS element alone (exclusive of any neural component), with respect to the RMS subtype, age of the patient, and anatomic location of the neoplasm.